Mylotarg and disease progression 
Mylotarg and disease progression Patient Reports February 09, 2010
Mylotarg Side Effects Report #4767617-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2005. Female patient, 81 years of age, weighting 204.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, disease progression, febrile neutropenia, lung neoplasm, lymphadenopathy mediastinal, scar
, splenomegaly. Mylotarg dosage: 14 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4957371-7
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, disease progression, epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient died on 03/10/2006.Mylotarg Side Effects Report #4969531-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 24, 2006. Male patient, 57 years of age, weighting 204.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, blood bilirubin increased, blood sodium decreased, chromaturia, condition aggravated, discomfort, disease progression, epistaxis. Mylotarg dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. During the same period patient was treated with ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, POTASSIUM CHLORIDE, PREVACID, COMPAZINE. Patient was hospitalized. Patient died on 03/10/2006.Mylotarg Side Effects Report #5276106-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Female patient, weighting 124.1 lb, was diagnosed with myelodysplastic syndrome, diabetes mellitus non-insulin-dependent, hypothyroidism, folate deficiency, hyperlipidaemia, candidiasis, pyrexia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, disorientation, infection
, mental status changes, pneumonia fungal, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with GLYBURIDE, LEVOTHYROXINE, FOLIC ACID, VYTORIN, FLUCONAZOLE, VITAMIN B, ACETAMINOPHEN. Patient was hospitalized. Patient died on 03/11/2007.Mylotarg Side Effects Report #5223408-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2007. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia recurrent, bacterial infection
, disease progression, febrile neutropenia, pneumonia , sepsis , white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, URSO, OMEPRAL, BAKTAR, DIFLUCAN, STRONG NEO MINOPHAGEN C. Patient died.Mylotarg Side Effects Report #5158527-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2006. Female patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, condition aggravated, disease progression, disseminated intravascular coagulation, febrile neutropenia, hyperuricaemia, hypokalaemia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with LIVALO, ENALAPRIL MALEATE, ADALAT OR, METHYCOBAL, ASPARA K, MUCOSOLVAN, LEVOFLOXACIN. Patient recovered.
Mylotarg Side Effects Report #4929638-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2006. Female patient, 73 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, disease progression, febrile neutropenia, hepatic enzyme increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient died on 09/05/2005.
Mylotarg Side Effects Report #5206754-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 27, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, enteritis, febrile neutropenia, gastrointestinal haemorrhage, hypokalaemia, hyponatraemia, liver disorder, lymphocyte percentage increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with RABEPRAZOLE, ISALON, VFEND, PANTOSIN, MAGNESIUM OXIDE, NEOPHAGEN, NEUPOGEN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5080806-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 28, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, condition aggravated, disease progression, gastrointestinal haemorrhage, hypocalcaemia, neutrophil count decreased, oral intake reduced, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with AMLODIPINE BESYLATE, LONGES, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5032003-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 06, 2006. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, haemorrhage, hypocalcaemia, neutrophil count decreased, oral intake reduced, platelet count decreased, pyrexia. Mylotarg dosage: 9 MG/M^2 PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with AMLODIPINE BESYLATE, LONGES, MUCOSTA, CHLORMADINONE ACETATE, HUMALOG, NOVOLIN N. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4844624-6
Mylotarg side effect was reported by a Health Professional from JAPAN on Nov 16, 2005. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: apnoea, blast cell count increased, blood pressure increased, disease progression, disseminated intravascular coagulation, dizziness
, febrile neutropenia, glucose urine present, hepatic failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, INSULIN, BASEN, BUFFERIN, RABEPRAZOLE, DAONIL, EVIPROSTAT, GLUCOBAY. Patient died.Mylotarg Side Effects Report #4917040-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Male patient, 68 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood pressure increased, disease progression, disseminated intravascular coagulation, dizziness
, febrile neutropenia, hepatic failure, hyperhidrosis, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, INSULIN, BASEN, BUFFERIN, RABEPRAZOLE, GLYBURIDE, EVIPROSTAT, GLUCOBAY. Patient died.Mylotarg Side Effects Report #4914259-5
Mylotarg side effect was reported by a Health Professional from JAPAN on Feb 07, 2006. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, cellulitis
, chills, disease progression, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ANASTROZOLE, FAMOTIDINE, LEVOFLOXACIN, BIOFERMIN R, SULFAMETHOXAZOLE, FLUCONAZOLE. Patient died.Mylotarg Side Effects Report #5053133-3
Mylotarg side effect was reported by a Health Professional from JAPAN on June 29, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE, ZOFRAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5019634-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blast cell count increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor xiii level decreased, condition aggravated, disease progression, febrile neutropenia. Mylotarg dosage: A SINGLE 7 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with ROXATIDINE ACETATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4837022-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2005. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, disease progression, hepatomegaly, leukaemia, pyrexia, sepsis
, venoocclusive liver disease. Mylotarg dosage: A SINGLE 6MG/M2 DOSE. During the same period patient was treated with CARBENIN, ISEPACIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ALBUMIN, ANTITHROMBIN III. Patient recovered.Mylotarg Side Effects Report #4887455-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 10, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, disease progression, sepsis
, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ALBUMIN, ANTITROMBIN III. Patient was hospitalized and became disabled. Patient recovered.Mylotarg Side Effects Report #5035407-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 09, 2006. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood pressure decreased, disease progression, disseminated intravascular coagulation, renal failure. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with MAXIPIME, MINOCYCLINE HYDROCHLORIDE, FUTHAN. Patient recovered.
Mylotarg Side Effects Report #4958838-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 14, 2006. Male patient, 52 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaphylactic reaction, cardiac failure congestive, chills, condition aggravated, disease progression, neutrophil percentage decreased, pneumonia
, pyrexia, white blood cell count decreased. Mylotarg dosage: A SINGLE 5 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BICARBONATE, HABEKACIN, LAMIVUDINE, FAMOTIDINE, MUCOSTA, SULFAMETHOXAZOLE, POLYMYXIN, FUNGIZONE. Patient died.Mylotarg Side Effects Report #5023801-8
Mylotarg side effect was reported by a Health Professional from JAPAN on May 23, 2006. Male patient, 52 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: cardiac failure congestive, condition aggravated, disease progression, infusion related reaction, neutrophil percentage decreased, pneumonia
, white blood cell count decreased. Mylotarg dosage: A SINGLE 5 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with BICARBONATE, HABEKACIN, LAMIVUDINE, FAMOTIDINE, MUCOSTA, SULFAMETHOXAZOLE, POLYMYXIN, FUNGIZONE. Patient died.Mylotarg Side Effects Report #5170515-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2006. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, depressed level of consciousness, disease progression, hyperammonaemia, pyrexia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP; 9 MG/M^2 1X PER 1 DAY; INTRAVENOUS DRIP. During the same period patient was treated with FUNGUARD, GALENIC, CLINDAMYCIN PHOSPHATE, CEFEPIME, MINOCYCLINE, VORICONAZOLE, ISEPAMICIN SULPHATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5085439-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 04, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, hepatic function abnormal, prothrombin time prolonged, pyrexia. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.
Mylotarg Side Effects Report #5113914-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 08, 2006. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood bilirubin increased, disease progression, hepatomegaly, lung injury, mouth haemorrhage, platelet count decreased, pseudomonal sepsis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with DAUNORUBICIN HYDROCHLORIDE, HYDREA, CIPROXAN, SULPERAZON, TOBRAMYCIN SULPHATE, FUNGUARD, VFEND, ZOVIRAX. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5019629-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, cerebral haemorrhage, coagulopathy, disease progression, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 6 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ZANTAC, PRODIF, MAXIPIME, BICARBONATE, OXYCONTIN, MAGNESIUM OXIDE, URSO. Patient died.
Mylotarg Side Effects Report #5235843-8
Mylotarg side effect was reported by a Physician from JAPAN on Jan 31, 2007. Male patient, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, disseminated intravascular coagulation, dyspnoea, fall
. Mylotarg dosage: unknown. During the same period patient was treated with LENDORMIN, ARTIST, TAKEPRON, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5238582-2
Mylotarg side effect was reported by a Physician from JAPAN on Feb 09, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, bacterial infection
, fungal infection , prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain , acute myeloid leukaemia, anorexia, dehydration, disease progression, fibrin degradation products increased, hepatitis , hiccups, immunosuppression. Mylotarg dosage: 16 MG (9 MG/M2/DAY). During the same period patient was treated with AMIKACIN SULPHATE, FUNGUARD, TIENAM, BAKTAR, ITRACONAZOLE. Patient recovered.Mylotarg Side Effects Report #5511142-1
Mylotarg side effect was reported by a Physician from JAPAN on Oct 30, 2007. Male patient, weighting 123.5 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood pressure diastolic increased, disease progression, gamma-glutamyltransferase increased. Mylotarg dosage: unknown. During the same period patient was treated with BAKTAR, OMEPRAZOLE, PROGRAF, UNIPHYL, BEZATOL, PREDONINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5636498-0
Mylotarg side effect was reported by a Physician from JAPAN on Feb 13, 2008. Male patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood lactate dehydrogenase increased, blood uric acid increased, disease progression, febrile neutropenia, hyperchloraemia, hyperkalaemia, hypernatraemia, hypoproteinaemia. Mylotarg dosage: unknown. During the same period patient was treated with FAMOTIDINE, ZYLORIC, LASIX, ITRIZOLE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5663249-6
Mylotarg side effect was reported by a Physician from JAPAN on Mar 10, 2008. Female patient, weighting 88.18 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood potassium decreased, blood sodium decreased, disease progression, hyperuricaemia, neutropenia, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with TAKEPRON, ITRIZOLE, OXYCONTIN, PENTCILLIN, BAKTAR, ZOLPIDEM, FUNGUARD, CRAVIT. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4986568-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 87 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression. Mylotarg dosage: A SINGLE 13.3 MG DOSE, INTRAVENOUS. Patient died on 03/26/2006.
Mylotarg Side Effects Report #5055695-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2006. Male patient, 85 years of age, weighting 160.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, asthenia, bacterial infection
, blast cell count decreased, blood culture positive, disease progression, fatigue, lethargy, leukopenia. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 10/17/2005.Mylotarg Side Effects Report #5071780-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2006. Male patient, 85 years of age, weighting 160.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blast cell count increased, disease progression, fatigue, lethargy, leukopenia, thrombocytopenia. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 10/17/2005.
Mylotarg Side Effects Report #4802758-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 85 years of age, weighting 141.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cellulitis
, deep vein thrombosis , disease progression, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 15.5 MG OVER 2 HOURS, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVAQUIN, DIFLUCAN, VALTREX, AMBIEN, TAMOXIFEN CITRATE, SENOKOT. Patient was hospitalized. Patient died on 04/27/2004.Mylotarg Side Effects Report #4802758-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 85 years of age, weighting 141.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cellulitis
, deep vein thrombosis , disease progression, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 15.5 MG OVER 2 HOURS, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVAQUIN, DIFLUCAN, VALTREX, AMBIEN, TAMOXIFEN CITRATE, SENOKOT. Patient was hospitalized. Patient died on 04/27/2004.Mylotarg Side Effects Report #5097834-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Male patient, 80 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, anaemia, cardio-respiratory arrest, coagulopathy, disease progression, epistaxis, haemoptysis, hiatus hernia. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 06/11/2005.
Mylotarg Side Effects Report #5032140-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2006. Male patient, 80 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardio-respiratory arrest, disease progression, epistaxis, haemoptysis, hypotension, melaena, myelodysplastic syndrome, respiratory distress. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 06/11/2005.
Mylotarg Side Effects Report #5113917-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 14, 2006. Female patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blast cell count increased, blood lactate dehydrogenase increased, c-reactive protein increased, disease progression, myeloblast count increased, pyrexia. Mylotarg dosage: A SINGLE 7.1 MG/M^2 DOSE. During the same period patient was treated with ZANTAC, LENDORM, DIFLUCAN, SOLON, MAGNESIUM OXIDE, ZOLPIDEM TARTRATE. Patient recovered.
Mylotarg Side Effects Report #5248543-5
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 09, 2007. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disease progression, hyperbilirubinaemia, hypokalaemia, hyponatraemia, neutropenic infection, neutrophil count decreased, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with DIAMOX, DIFLUCAN. Patient died.
Mylotarg Side Effects Report #5074408-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 26, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, disease recurrence and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, febrile neutropenia, hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CEFTAZIDIME, SULPERAZON, POLYMYXIN B SULPHATE, ULCERMIN, ALLOPURINOL, DIFLUCAN. Patient recovered.
Mylotarg Side Effects Report #5093595-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood calcium decreased, blood potassium decreased, blood urea increased, disease progression, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.
Mylotarg Side Effects Report #5094439-1
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, band neutrophil percentage decreased, disease progression, hyperbilirubinaemia, hypokalaemia, hyponatraemia, neutrophil count decreased, platelet count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with DIAMOX, DIFLUCAN. Patient died.
Mylotarg Side Effects Report #5097255-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disease progression, hyperbilirubinaemia, hypokalaemia, hyponatraemia, neutrophil count decreased, platelet count decreased, pneumonia
. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with DIAMOX, DIFLUCAN. Patient died.Mylotarg Side Effects Report #5134042-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 11, 2006. Female patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood lactate dehydrogenase increased, disease progression, eating disorder
, febrile neutropenia, hyperuricaemia, hypoproteinaemia, infection , infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with FOSMICIN S, MAXIPIME, NIZATIDINE, SUCRALFATE, LASIX, DAUNORUBICIN HYDROCHLORIDE, ENOCITAMINE. Patient recovered.Mylotarg Side Effects Report #5002555-5
Mylotarg side effect was reported by a Health Professional from JAPAN on Apr 28, 2006. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disease progression, hyperbilirubinaemia, hypokalaemia, hyponatraemia, neutrophil count decreased, platelet count decreased, pneumonia
. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. Patient died.Mylotarg Side Effects Report #4639306-X
Mylotarg side effect was reported by a Consumer or non-health professional from on Apr 06, 2005. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blast cell count increased, blood glucose increased, disease progression, febrile neutropenia, headache
, nausea . Mylotarg dosage: unknown. During the same period patient was treated with FOLIC ACID, ACYCLOVIR, NORVASC, ACCUPRIL, ATENOLOL, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4851409-3
Mylotarg side effect was reported by a Health Professional from JAPAN on Nov 29, 2005. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood creatinine increased, blood urea increased, cardiac failure, disease progression, hyperhidrosis, hypotension, infusion related reaction, pneumonia
. Mylotarg dosage: 7 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. Patient died.Mylotarg Side Effects Report #4870092-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2002. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, disease progression, platelet count decreased, pneumonia fungal. Mylotarg dosage: 8.297 MG 1X PER 1 DAY, INTRAVENOUS; 5.53 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ACYCLOVIR, PERIDEX, PREVACID, FLUCONAZOLE, GENTAMICIN, LEVOFLOXACIN. Patient died on 09/05/2002.
Mylotarg Side Effects Report #4875157-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2005. Male patient, 77 years of age, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood potassium decreased, csf protein increased, disease progression, febrile neutropenia, haemoglobin decreased, headache
. Mylotarg dosage: unknown. During the same period patient was treated with FOLIC ACID, ACYCLOVIR, NORVASC, ACCUPRIL, ATENOLOL, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4893551-7
Mylotarg side effect was reported by a Health Professional from JAPAN on Jan 12, 2006. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood pressure diastolic decreased, body temperature decreased, contusion, disease progression, fall
, head injury, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with AMLODIPINE BESYLATE, BEPRIDIL HYDROCHLORIDE MONOHYDRATE, DIOVAN. Patient died.Mylotarg Side Effects Report #4929386-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 16, 2006. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arteriosclerosis, body temperature increased, cardiac failure, disease progression, electrocardiogram abnormal, hyperhidrosis, hypotension, infusion related reaction, thrombosis. Mylotarg dosage: 7 MG/M^2 1X PER 1 DAY INRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ALLOPURINOL, DEXAMETHASONE PHOSPHATE, DEXAMETHASONE PHOSPHATE, CHLORPHENIRAMINE MALEATE, CHLORPHENIRAMINE MALEATE. Patient died.
Mylotarg Side Effects Report #4952646-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 30, 2004. Male patient, 77 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal pain upper, confusional state, cryptogenic organizing pneumonia, disease progression, hiccups, insomnia, obliterative bronchiolitis, pancytopenia, pleural effusion. Mylotarg dosage: 16 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PROTONIX, SPORANOX, MONOPRIL, COMBIVENT, LASIX, LEVAQUIN, FLAGYL. Patient was hospitalized. Patient died on 04/30/2003.
Mylotarg Side Effects Report #4970755-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 29, 2006. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood creatinine increased, blood urea increased, c-reactive protein increased, cardiac failure, disease progression, electrocardiogram abnormal, hyperhidrosis, hypotension. Mylotarg dosage: 7 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ALLOPURINOL, DEXAMETHASONE PHOSPHATE, CHLORPHENIRAMINE MALEATE. Patient died.
Mylotarg Side Effects Report #4949325-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 76 years of age, weighting 214.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, chills, disease progression, infusion related reaction, weight increased. Mylotarg dosage: 17 MG, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #4696392-9
Mylotarg side effect was reported by a Consumer or non-health professional from on June 08, 2005. Male patient, 75 years of age, weighting 240.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, bacillus infection, biliary dilatation, blood calcium decreased, blood potassium decreased, candidiasis, cholelithiasis, disease progression, dyspnoea exertional. Mylotarg dosage: 20 MG 1X PER 1 DAY; INTRAVENOUS. Patient was hospitalized. Patient died on 08/09/2004.
Mylotarg Side Effects Report #5091413-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2006. Male patient, 74 years of age, weighting 137.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, chills, disease progression, hypotension, infusion related reaction. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 04/16/2005.
Mylotarg Side Effects Report #4949974-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 74 years of age, weighting 168.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, chills, disease progression, infection
, infusion related reaction, pyrexia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, METOPROLOL, ISOSORBIDE, DIPHENHYDRAMINE, ALLOPURINOL, NEXIUM, ACETAMINOPHEN. Patient was hospitalized. Patient died on 12/30/2002.Mylotarg Side Effects Report #4958840-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood potassium decreased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion, pulmonary oedema. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.
Mylotarg Side Effects Report #4977027-4
Mylotarg side effect was reported by a Physician from UNITED STATES on Mar 30, 2006. Male patient, 74 years of age, weighting 168.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, infection
, infusion related reaction, nausea , pyrexia, white blood cell count decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, METOPROLOL, ISOSORBIDE, DIPHENHYDRAMINE, ALLOPURINOL, NEXIUM, ACETAMINOPHEN. Patient was hospitalized. Patient died on 12/30/2002.Mylotarg Side Effects Report #4998575-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood urea increased, body temperature increased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5029635-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myocardial infarction, chills, disease progression, hypotension, infusion related reaction, liver function test abnormal, pancytopenia, pyrexia, renal failure acute. Mylotarg dosage: unknown. Patient was hospitalized. Patient died on 04/16/2005.
Mylotarg Side Effects Report #5047652-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood chloride increased, blood glucose increased, cardiomegaly, catheter related infection, disease progression, dyspnoea, febrile neutropenia, haemoglobin decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5150679-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia, leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, hypoxia, infection
, interstitial lung disease, weight increased, white blood cell count decreased, white blood cell count increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ORGARAN, FIRSTCIN, FUNGUARD, AMARYL, METFORMIN HYDROCHLORIDE, DIOVAN. Patient died.Mylotarg Side Effects Report #4802759-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, blood glucose increased, cardiomegaly, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4949574-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 73 years of age, weighting 114.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, central line infection, chills, disease progression, dyspnoea, febrile neutropenia, haematocrit decreased, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with PREDNISONE, PREVACID, SENOKOT, VITAMINS NOS, ZOSYN, DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4967137-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2006. Male patient, 73 years of age, weighting 134.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, disease progression, hepatic failure, hepatomegaly, malaise, pleural effusion, renal failure acute, splenomegaly. Mylotarg dosage: 15.3 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, ATENOLOL, FUROSEMIDE, FLUCONAZOLE, LISINOPRIL, POTASSIUM CHLORIDE, NITROGLYCERIN TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5152761-4
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Nov 02, 2006. Male patient, 72 years of age, weighting 173.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: chills, disease progression, dyspnoea, headache
, hypoaesthesia, infusion related reaction, nausea , pulmonary oedema, pyrexia. Mylotarg dosage: unknown. During the same period patient was treated with CIPRO. Patient died on 03/18/2005.Mylotarg Side Effects Report #4952733-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2004. Male patient, 72 years of age, weighting 321.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, haemoglobin decreased, neutrophil count decreased, platelet count decreased, pyrexia, shoulder pain, white blood cell count decreased. Mylotarg dosage: unknown. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4978538-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2006. Female patient, 71 years of age, weighting 192.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, disease progression, dyspnoea, weight increased. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5084590-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bacterial sepsis, disease progression, dyspnoea, febrile neutropenia, haemoglobin decreased, hypotension, staphylococcal infection
, thrombocytopenia. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #5096605-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2006. Female patient, 70 years of age, weighting 140.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bacterial sepsis, blood culture positive, disease progression, dyspnoea, febrile neutropenia, hypotension, myelodysplastic syndrome, staphylococcal infection
. Mylotarg dosage: 16 MG IV EVERY 14 DAYS, INTRAVENOUS. During the same period patient was treated with GLUCOTROL, IMMUNE SERUM GLOBULIN. Patient was hospitalized. Patient died on 04/12/2003.Mylotarg Side Effects Report #4986553-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 70 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, chills, disease progression, dizziness
, dyspnoea, febrile neutropenia, fluid overload. Mylotarg dosage: 18.9 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 01/08/2006.Mylotarg Side Effects Report #4962833-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 20, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, febrile neutropenia, herpes zoster, hypokalaemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with MEROPEN, GRAVIT, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE, BROTIZOLAM. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4996486-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, febrile neutropenia, herpes zoster, hypocalcaemia, hypokalaemia, renal impairment. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACICLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4998731-8
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, disease recurrence, sepsis
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with FAMOTIDINE, PANTOSIN, MAGNESIUM OXIDE, LASIX, KYTRIL, LOXONIN, MUCOSTA. Patient recovered.Mylotarg Side Effects Report #5032005-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on June 08, 2006. Female patient, 69 years of age, was diagnosed with acute myeloid leukaemia, herpes zoster and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, febrile neutropenia, hepatic function abnormal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with ACYCLOVIR, ETOPOSIDE, MEROPEN, LEVOFLOXACIN, DIFLUCAN, FAMOTIDINE, PREDNISOLONE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5105262-3
Mylotarg side effect was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Female patient, 68 years of age, weighting 199.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bronchioloalveolar carcinoma, disease progression, febrile neutropenia, lymphoma
, pericardial effusion, pleural effusion, pneumonia , pulmonary oedema. Mylotarg dosage: SINGLE DOSE OF 11.4 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, FUROSEMIDE, ZOSYN, LEVOFLOXACIN, VORICONAZOLE, CEFEPIME, NEUPOGEN. Patient died on 12/23/2004.Mylotarg Side Effects Report #4870017-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2005. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia, pneumonia
, post procedural complication. Mylotarg dosage: SINGLE DOSE OF 11.4 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient died on 12/23/2004.Mylotarg Side Effects Report #5082287-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, carbon dioxide decreased, chest x-ray abnormal, disease progression, febrile neutropenia, leukaemic infiltration pulmonary, renal failure acute. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with HYDROXYUREA. Patient died on 10/26/2005.
Mylotarg Side Effects Report #5105192-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Male patient, 67 years of age, weighting 183.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood glucose increased, blood sodium decreased, disease progression, febrile neutropenia, renal cyst, renal failure acute, vascular calcification. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with HYDROXYUREA, LORAZEPAM, ALLOPURINOL, TRAZODONE, ATENOL, VANCOMYCIN, DOCUSATE, SENNA. Patient died on 10/26/2005.
Mylotarg Side Effects Report #5119233-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2006. Male patient, 67 years of age, weighting 183.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acquired diaphragmatic eventration, blast cell count increased, blood sodium decreased, disease progression, febrile neutropenia, pleural effusion, renal cyst, renal failure acute, spinal fusion acquired. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with HYDROXYUREA, LORAZEPAM, ALLOPURINOL, TRAZODONE, ATENOL, VANCOMYCIN, DOCUSATE, SENNA. Patient died on 10/26/2005.
Mylotarg Side Effects Report #5092802-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 17, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, disease progression, haemolytic anaemia, haemorrhagic diathesis, neutrophil count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with DIFLUCAN, ISONIAZID, STREPTOMYCIN SULPHATE, FUNGUARD, MEROPEN, NEUPOGEN, PREDNISOLONE. Patient died.
Mylotarg Side Effects Report #5128900-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 09, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased, infusion related reaction. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPRO, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #4949624-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #5051531-5
Mylotarg side effect was reported by a Health Professional from UNITED STATES on June 28, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, liver function test abnormal, oedema. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVNEOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #5073159-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #4706836-1
Mylotarg side effect was reported by a Physician from UNITED STATES on Nov 11, 2004. Male patient, 63 years of age, weighting 235.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, chills, delirium, depression
, diarrhoea, disease progression, disease recurrence, febrile neutropenia. Mylotarg dosage: 9 MG/M(2) ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, LEVOFLOXACIN, FLUCONAZOLE, ACYCLOVIR, IMIPENEM, FLAGYL, LACTAID. Patient was hospitalized and became disabled. Patient died on 06/26/2002.Mylotarg Side Effects Report #4809726-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 02, 2004. Male patient, 63 years of age, weighting 235.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, chest x-ray abnormal, chills, delirium, depression
, diarrhoea, disease progression, febrile neutropenia. Mylotarg dosage: unknown. During the same period patient was treated with ALLOPURINOL, FLUCONAZOLE, ACYCLOVIR, IMIPENEM. Patient was hospitalized and became disabled. Patient died on 06/26/2002.Mylotarg Side Effects Report #4863969-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 07, 2005. Male patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acidosis, activated partial thromboplastin time prolonged, acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with METHOTREXATE. Patient died.
Mylotarg Side Effects Report #4867683-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Apr 13, 2002. Female patient, 63 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cells present, blood lactate dehydrogenase increased, disease progression, febrile neutropenia, leukopenia, nausea
, thrombocytopenia. Mylotarg dosage: 9 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5105193-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Male patient, 62 years of age, weighting 160.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood calcium decreased, carbon dioxide decreased, disease progression, dyspnoea, fluid overload, hypovolaemia. Mylotarg dosage: A SINGLE 10 MG, DOSE, INTRAVENOUS; 11 MG, INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE, PANTOPRAZOLE, ACYCLOVIR, ACETAMINOPHEN, DIPHENHYDRAMINE, LORAZEPAM. Patient died on 12/29/2004.
Mylotarg Side Effects Report #4736479-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2005. Male patient, 60 years of age, weighting 158.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspiration, cerebral haemorrhage, confusional state, cytomegalovirus infection
, disease progression, disorientation, epistaxis, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 4 MG/M^2, INTRAVENOUS. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, DAPSONE, CIPROFLOXACIN, VALACYCLOVIR, CYCLOSPORINE, PRILOSEC. Patient was hospitalized. Patient died on 01/12/2001.Mylotarg Side Effects Report #4787303-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2005. Male patient, 60 years of age, weighting 158.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspiration, cerebral haemorrhage, confusional state, cytomegalovirus infection
, disease progression, disorientation, epistaxis, haematocrit decreased, haemoglobin decreased. Mylotarg dosage: 4 MG/M^2, INTRAVENOUS. During the same period patient was treated with PREDNISONE, MYCOPHENOLATE MOFETIL, DAPSONE, CIPROFLOXACIN, VALACYCLOVIR, CYCLOSPORINE, PRILOSEC. Patient was hospitalized. Patient died on 01/12/2001.Mylotarg Side Effects Report #4948798-8
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 287.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood pressure increased, dialysis
, disease progression, hepatic steatosis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with INSULIN, ACYCLOVIR, ALLOPURINOL, NORVASC, FIBRALAX, CIPROFLOXACIN, KLONOPIN. Patient was hospitalized. Patient died on 11/01/2003.Mylotarg Side Effects Report #4948877-5
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 60 years of age, weighting 146.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, chills, condition aggravated, disease progression, fluid overload, hypotension, infusion related reaction, multi-organ failure, oxygen saturation decreased. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient died on 10/24/2003.
Mylotarg Side Effects Report #5104158-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 31, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blast cell count increased, blood bilirubin increased, disease progression, hepatic function abnormal, lactic acidosis, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with PRODIF, FIRSTCIN, OMEPRAZOLE, STRONG NEO MINOPHAGEN C. Patient died.
Mylotarg Side Effects Report #5119352-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 22, 2006. Male patient, 57 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac failure congestive, disease progression, dysuria, febrile neutropenia, infusion related reaction, myalgia, obstruction gastric, pancreatitis acute. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, ALLOPURINOL, AMBIEN, PREVACID, PHYTONADIONE, CELEBREX. Patient was hospitalized. Patient died on 09/07/2002.
Mylotarg Side Effects Report #5122858-3
Mylotarg side effect was reported by a Physician from UNITED STATES on Sept 22, 2006. Male patient, 57 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: bile duct obstruction, cardiac failure congestive, diarrhoea, disease progression, dysuria, febrile neutropenia, gastrointestinal disorder, infusion related reaction, malignant neoplasm progression. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, ALLOPURINOL, AMBIEN, PREVACID, PHYTONADIONE, CELEBREX. Patient was hospitalized. Patient died on 09/07/2002.
Mylotarg Side Effects Report #4952754-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 29, 2004. Male patient, 57 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anorexia, bile duct obstruction, bone marrow leukaemic cell infiltration, cardiac failure congestive, diarrhoea, disease progression, dysuria, febrile neutropenia. Mylotarg dosage: 17 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, VALTREX, ALLOPURINOL, AMBIEN, PREVACID, VITAMIN K, CELEBREX. Patient was hospitalized. Patient died on 09/07/2002.
Mylotarg Side Effects Report #5060481-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: disease progression, febrile neutropenia, staphylococcal infection
, white blood cell count decreased. Mylotarg dosage: unknown. During the same period patient was treated with PROVIGIL, GLUCOTROL, TRAMADOL, DIFLUCAN, ACYCLOVIR, TEQUIN, PROTONIX. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5071787-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood culture positive, disease progression, febrile neutropenia, staphylococcal infection
. Mylotarg dosage: unknown. During the same period patient was treated with PROVIGIL, GLUCOTROL, TRAMADOL, DIFLUCAN, ACYCLOVIR, TEQUIN, PROTONIX. Patient was hospitalized. Patient died on 08/19/2004.Mylotarg Side Effects Report #5023602-0
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2006. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, condition aggravated, disease progression, disseminated intravascular coagulation, pyrexia, venoocclusive liver disease. Mylotarg dosage: unknown. During the same period patient was treated with CARBENIN, MAXIPIME, AMIKACIN SULPHATE, PRODIF, ANTITHROMBIN III, FRAGMIN. Patient recovered.